Kerala has constituted a six-member inspection team to monitor medicine stocks at all 14 district drug warehouses and two sub-warehouses operated by the Kerala Medical Services Corporation Ltd (KMSCL), in an effort to prevent expiry-related losses and improve supplies to government hospitals.
The team will conduct both regular and surprise inspections of the warehouses. Its responsibilities include physically checking stocks, comparing quantities with entries in KMSCL’s drug distribution management system and identifying gaps between recorded and actual inventory.
The inspection panel will be headed by retired superintendent of police P Gopakumaran Nair. Its members include Health and Family Welfare Department under secretary Biju Kumar T, Drugs Control Department assistant drugs controller Vinod V, In-House Drug Bank chief pharmacist A Biju, a pharmacist nominated by KMSCL, and Dr Suresh Kumar G, a retired technical officer of the medical education department and senior consultant engineer at HLL Lifecare Ltd.
The team has also been asked to examine slow-moving medicines and stocks approaching their expiry dates. The inspections will cover storage conditions, inventory management practices and the procedures followed for disposing of expired medicines.
The move places the entire public medicine supply chain under a more systematic inspection framework. KMSCL warehouses serve as an important link between medicines procured by the state and their eventual distribution to government hospitals. Any mismatch between warehouse records and physical stock can affect the timing of hospital supplies, while medicines that remain unused until expiry can result in the loss of public funds.
The exercise is intended to identify shortcomings in procurement, storage and distribution that may contribute either to shortages at hospitals or to the accumulation of medicines that are not being used. By including surprise inspections, the government is seeking to assess warehouse operations beyond scheduled stock reviews.
The team’s work will also examine whether medicines are being distributed in time and whether storage facilities and inventory practices are supporting effective stock rotation. Particular attention to slow-moving and near-expiry medicines could help authorities identify stocks that require faster redistribution or closer monitoring.
The inspection mechanism is expected to provide the government with an independent assessment of KMSCL’s warehouse operations. The composition of the team brings together representatives and specialists linked to health administration, drug regulation, pharmacy, medical education, engineering and law-enforcement experience.
The team leader will submit periodic reports to the government. These reports will detail the findings of inspections, shortcomings identified during the exercise and recommendations for corrective measures. The government will use the reports to strengthen accountability within KMSCL and improve the movement of medicines from warehouses to public hospitals.
